 BURLINGTON, Mass., Jan. 13, 2021 GLOBE NEWSWIRE -- Flexion Therapeutics, Inc. Nasdaq:FLXN today announced preliminary and unaudited net sales for the fourth quarter and full year ended December 31, 2020. 